June 23, 2022 Press release - Non-regulatory Targovax announces that the FDA has granted authorization to initiate clinical trials with the enhanced TG01 RAS vaccine in the USA
June 23, 2022 Press release - Non-regulatory Targovax: FDA gir tillatelse til å starte kliniske studier med ny og forbedret TG01 kreftvaksine i USA
June 7, 2022 Press release - Regulatory Targovax ASA: Registration of share capital increase following settlement of restricted stock units and exercise of employee options
May 31, 2022 Press release - Regulatory Targovax ASA: Mandatory notification of trade by primary insiders pertaining to RSUs
May 31, 2022 Press release - Regulatory Targovax ASA: Exercise of options, settlement of restricted stock units and resolutions to increase the share capital
May 27, 2022 Press release - Non-regulatory Targovax announces publication of the two abstracts accepted for poster presentation at ASCO 2022
May 11, 2022 Press release - Regulatory Targovax announces clinical collaboration with Agenus for upcoming ONCOS-102 phase 2 melanoma trial
May 10, 2022 Press release - Non-regulatory Targovax and Oslo University Hospital announce collaboration to test TG mutant RAS vaccination in multiple myeloma
May 3, 2022 Press release - Non-regulatory Targovax ASA: Invitation to presentation of Targovax’s first quarter 2022 results, Thursday 12 May
April 28, 2022 Press release - Non-regulatory Targovax ASA: Two ONCOS-102 abstracts accepted for ASCO
April 26, 2022 Press release - Non-regulatory Targovax to present at 5th Neoantigen Summit Europe in Amsterdam
April 21, 2022 Press release - Non-regulatory Targovax ASA announces the appointment of two new Board Directors
April 20, 2022 Press release - Regulatory Targovax ASA: Issuance of restricted stock units (RSUs) to the board members
March 9, 2022 Press release - Non-regulatory Targovax ASA: Poster presentation at the AACR Annual Meeting
March 8, 2022 Press release - Regulatory Targovax ASA: Registration of share capital increases following exercise of options
March 7, 2022 Press release - Non-regulatory Targovax ASA and Agenus announce collaboration on mutant KRAS cancer vaccine adjuvanted with QS-21 STIMULON™
March 2, 2022 Press release - Regulatory Targovax ASA: Mandatory notification of trade by primary insider in connection with settlement of RSUs
March 2, 2022 Press release - Regulatory Targovax ASA: Exercise of options under LTI program, settlement of RSUs and resolution to increase the share capital
February 28, 2022 Press release - Regulatory Targovax ASA strengthens management with Lubor Gaal as Chief Financial Officer
February 9, 2022 Press release - Regulatory Targovax ASA: Invitation to presentation of Targovax’s fourth quarter 2021 results, Thursday 17 February
February 1, 2022 Press release - Non-regulatory Targovax inngår forskningssamarbeid med Karolinska Institutet (Norwegian)
February 1, 2022 Press release - Regulatory Targovax and Prof. Michael Uhlin at Karolinska Institutet enter research collaboration
January 17, 2022 Press release - Non-regulatory Targovax granted Patents for ONCOS-102 in combination with chemotherapy in China and Japan
January 12, 2022 Press release - Regulatory Targovax ASA: Targovax awarded NOK 8.2m grant by Innovation Norway
